会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明授权
    • Process for producing carboxylic acid isomer using Nocardia diaphanozonaria or Saccharopolyspora hirsuta
    • 使用诺卡氏菌(Nocardia diaphanozonaria)或酿酒酵母(Saccharopolyspora hirsuta)生产羧酸异构体的方法
    • US06365399B1
    • 2002-04-02
    • US09625323
    • 2000-07-25
    • Yoshiki TakashimaYuko Kobayashi
    • Yoshiki TakashimaYuko Kobayashi
    • C12P4100
    • C12P7/40C12N9/90C12P17/00C12P41/00
    • The present invention provides a process for producing a carboxylic acid isomer B represented by the general formula (2): (wherein, L is a C6 to C14 aryl group which may optionally been substituted, C4 to C12 heteroaryl group which may optionally been substituted, C6 to C14 aryloxy group which may optionally been substituted or C4 to C12 heteroaryloxy group which may optionally been substituted, and M is an C1 to C3 alkyl group.), which comprises: allowing a carboxylic acid isomer A represented by the general formula (1):  (wherein, L and M have meanings as defined above.) to contact with a microbiological material having an ability to convert the carboxylic acid isomer A(1) into the carboxylic acid isomer B(2), and the like. According to the present invention, the carboxylic acid isomer B(2) useful as an intermediate of medicines, agricultural chemicals and like can be produced efficiently.
    • 本发明提供一种由通式(2)表示的羧酸异构体B的制备方法:其中,L为任选被取代的C 6〜C 14芳基,可任选被取代的C 4〜C 12杂芳基, 可任选被取代的C 6至C 14芳氧基或可任选被取代的C 4至C 12杂芳氧基,M为C 1至C 3烷基),其包括:使由通式(1)表示的羧酸异构体A )(其中,L和M具有如上定义的含义)与具有将羧酸异构体A(1)转化成羧酸异构体B(2)的能力的微生物材料接触等。 根据本发明,可有效地制备可用作药物,农药等的中间体的羧酸异构体B(2)。